German study reveals $10 allergy spray cuts COVID risk by 67%... Will Big Pharma bury it like ivermectin?
By isabelle // 2025-09-05
Copy
 
  • A peer-reviewed German study reveals a $10 over-the-counter nasal spray reduces COVID-19 infection risk by 67%.
  • The FDA-approved antihistamine spray, azelastine, is safe, affordable, and weakens virus severity yet faces likely suppression.
  • Big Pharma’s financial interests conflict with cheap, effective treatments, mirroring past censorship of ivermectin and hydroxychloroquine.
  • The CDC and media have repeatedly ignored or demonized non-pharmaceutical COVID solutions despite proven benefits.
  • High-risk groups could benefit immediately, but corporate control over medicine may block access to this life-saving option.
When the COVID-19 pandemic first hit, we were told to wait for a vaccine—no questions asked. Then, when safe, affordable treatments like ivermectin and hydroxychloroquine emerged, they were demonized, censored, and buried under a mountain of corporate-funded disinformation. Now, a peer-reviewed German study has found that a $10 over-the-counter nasal spray already sitting on pharmacy shelves could cut COVID-19 infection risk by 67%. So why isn’t every doctor, news outlet, and public health official screaming this from the rooftops? The answer, as always, comes down to money, control, and the pharmaceutical industry’s death grip on medicine.

A simple spray with stunning results

Researchers at Saarland University Hospital in Germany conducted a double-blind, placebo-controlled trial with 450 healthy adults, testing whether azelastine, a common antihistamine nasal spray sold as Astepro Allergy, could prevent COVID-19. The results, published in JAMA Internal Medicine, were undeniable. Participants who used the spray three times daily saw their infection risk plummet by 67% compared to the placebo group. Only 2.2% of azelastine users tested positive for COVID, versus 6.7% in the placebo group. Even those who did get infected had milder symptoms, shorter illnesses, and delayed onset, indicating that the spray didn’t just prevent infection; it weakened the virus’s impact. Dr. Bruce Hirsch, an infectious disease specialist at Northwell Health, told The New York Post that the findings make sense. "If a medication is soothing the lining of the upper respiratory tract, there’s going to be less inflammation," he explained. "With less tissue disruption, there’ll be less opportunity for viruses to get going and cause mischief."

Safe, cheap, and already FDA-approved... so what’s the problem?

Azelastine isn’t some experimental drug rushed through emergency authorization. It’s been FDA-approved for decades, with a long safety record and minimal side effects—mostly just a bitter taste or occasional nosebleed. Unlike COVID vaccines, which were pushed on the public with zero long-term safety data, this spray has been used by millions of allergy sufferers without issue. Yet instead of celebrating this breakthrough, the medical establishment will likely ignore it, downplay it, or—if past behavior is any indication—actively suppress it. We’ve seen this movie before. Ivermectin, a Nobel Prize-winning drug with a near-perfect safety profile, was smeared as "horse dewormer" by the media and banned from discussion by Big Tech despite dozens of studies showing its effectiveness against COVID. Hydroxychloroquine, another safe, generic drug, was falsely linked to heart problems in fraudulent studies. Now, azelastine—a drug so safe it’s sold over the counter—faces the same corporate censorship machine. Will the FDA send warning letters to companies promoting it? Will YouTube and Facebook ban posts about it? Will the CDC pretend it doesn’t exist, just like they did with vitamin D, zinc, and quercetin? Why would they suppress a cheap, effective treatment? Follow the money. COVID-19 has been a $100 billion bonanza for Pfizer, Moderna, and the vaccine industry. The last thing they want is a $10 nasal spray cutting into their profits. Remember: Vaccines were granted emergency use authorization on the condition that no other effective treatments existed. If a simple spray reduces infections by 67%, that undermines the entire narrative that vaccines were the only solution. And let’s not forget the CDC’s track record of silence on non-pharmaceutical treatments. They ignored nasal rinses with xylitol and povidone-iodine, despite studies proving they neutralize the virus. They censored doctors who recommended ivermectin and hydroxychloroquine. They pretended vitamin D didn’t work, even when hospitalized patients saw dramatic improvements. This isn’t about public health. It’s about protecting a predatory industry that profits from sickness, not wellness.

A tool for the vulnerable—if they’re allowed to use it

The German researchers explicitly stated that azelastine could be especially useful for high-risk groups—the elderly, immunocompromised, or those in crowded settings like nursing homes and hospitals. Unlike vaccines, which lose effectiveness against new variants, this spray works regardless of the strain. But will doctors actually recommend it? Or will they wait for "more studies"—the same excuse used to delay ivermectin and hydroxychloroquine until it was too late? Sources for this article include: YourNews.com FoxNews.com NYPost.com
Copy